Correlation Between HEMOGENYX PHARMPLC and Apple

Can any of the company-specific risk be diversified away by investing in both HEMOGENYX PHARMPLC and Apple at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HEMOGENYX PHARMPLC and Apple into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between HEMOGENYX PHARMPLC LS 01 and Apple Inc, you can compare the effects of market volatilities on HEMOGENYX PHARMPLC and Apple and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HEMOGENYX PHARMPLC with a short position of Apple. Check out your portfolio center. Please also check ongoing floating volatility patterns of HEMOGENYX PHARMPLC and Apple.

Diversification Opportunities for HEMOGENYX PHARMPLC and Apple

-0.09

Correlation Coefficient

HEMOGENYX PHARMPLC  Apple

Good diversification

The 3 months correlation between HEMOGENYX and Apple is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding HEMOGENYX PHARMPLC LS 01 and Apple Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apple Inc and HEMOGENYX PHARMPLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HEMOGENYX PHARMPLC LS 01 are associated (or correlated) with Apple. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apple Inc has no effect on the direction of HEMOGENYX PHARMPLC i.e., HEMOGENYX PHARMPLC and Apple go up and down completely randomly.

Pair Corralation between HEMOGENYX PHARMPLC and Apple

Assuming the 90 days horizon HEMOGENYX PHARMPLC LS 01 is expected to generate 32.95 times more return on investment than Apple. However, HEMOGENYX PHARMPLC is 32.95 times more volatile than Apple Inc. It trades about 0.05 of its potential returns per unit of risk. Apple Inc is currently generating about 0.1 per unit of risk. If you would invest  1,340  in HEMOGENYX PHARMPLC LS 01 on October 4, 2024 and sell it today you would lose (881.00) from holding HEMOGENYX PHARMPLC LS 01 or give up 65.75% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

HEMOGENYX PHARMPLC LS 01  vs.  Apple Inc

HEMOGENYX PHARMPLC

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in HEMOGENYX PHARMPLC LS 01 are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, HEMOGENYX PHARMPLC reported solid returns over the last few months and may actually be approaching a breakup point.

Apple Inc

Risk-Adjusted Performance

21 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Apple Inc are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile fundamental indicators, Apple unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with HEMOGENYX PHARMPLC and Apple

The main advantage of trading using opposite HEMOGENYX PHARMPLC and Apple positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HEMOGENYX PHARMPLC position performs unexpectedly, Apple can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apple will offset losses from the drop in Apple's long position.

The idea behind HEMOGENYX PHARMPLC LS 01 and Apple Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.